Out of Specification (OOS) in pharma Industry: Complete Investigation Guide & Prevention in 2026

Out of Specification (OOS) events represent a crucial quality challenge in pharmaceuticals, impacting product safety and regulatory compliance. Occurring in 2.3% of samples in 2026, these events demand thorough investigations and corrective actions. This blog explores the causes, investigation steps, and prevention strategies to help pharmaceutical companies strengthen their quality systems and maintain trust in their products.